DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

B. Riley FBR Maintains Buy on Cormedix, Lowers Price Target to $10

B. Riley FBR analyst Andrew D'Silva maintains Cormedix (AMEX:CRMD) with a Buy and lowers the price target from $15 to $10.

Benzinga · 03/18/2020 11:09

B. Riley FBR analyst Andrew D'Silva maintains Cormedix (AMEX:CRMD) with a Buy and lowers the price target from $15 to $10.